2006/001 NICE consults on revised first draft guidance on the use of drugs to treat Alzheimer's disease
The National Institute for Health Clinical Excellence (NICE) is consulting on the
revised draft of its review of donepezil, rivastigmine, galantamine and memantine for the treatment of Alzheimer's disease. The document has been published on the NICE website 2006 for a three week public consultation period which ends on 13 February 2006.
 |
2006/001 NICE consults on revised first draft guidance on the use of drugs to treat Alzheimer´s disease 20 January 2006 (36.6Kb 13sec @ 28.8Kbps) |
